Effect of sorghum ethyl-acetate extract on benign prostatic hyperplasia induced by testosterone in Sprague–Dawley rats

References

• Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol. 2005;7(Suppl 9):S3–S14. PubMed PMID: 16985902; PubMed Central PMCID: PMCPMC1477638.
   PubMedGoogle Scholar
• Park HJ, Won JE, Sorsaburu S, et al. Urinary Tract Symptoms (LUTS) secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with erectile dysfunction in Asian men: a systematic review focusing on tadalafil. World J Mens Health. 2013 Dec;31(3):193–207. PubMed PMID: 24459652; PubMed Central PMCID: PMCPMC3888888.
   PubMedGoogle Scholar
• Berges R, Hofner K, Gedamke M, et al. Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). World J Urol. 2014 Oct;32(5):1163–1170. PubMed PMID: 25135845.
   PubMed Web of Science ®Google Scholar
• Moul S, McVary KT. Lower urinary tract symptoms, obesity and the metabolic syndrome. Curr Opin Urol. 2010 Jan;20(1):7–12. PubMed PMID: 19904208.
   PubMed Web of Science ®Google Scholar
• Rohrmann S, Giovannucci E, Willett WC, et al. Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men. Am J Clin Nutr. 2007 Feb;85(2):523–529. PubMed PMID: 17284753.
   PubMed Web of Science ®Google Scholar
• Parsons JK, Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol. 2008 Jun;53(6):1228–1235. PubMed PMID: 18358592.
   PubMed Web of Science ®Google Scholar
• Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol. 2007 Aug;178(2):395–401. PubMed PMID: 17561143.
   PubMed Web of Science ®Google Scholar
• Dimitropoulos K, Gravas S. New therapeutic strategies for the treatment of male lower urinary tract symptoms. Res Rep Urol. 2016;8:51–59. PubMed PMID: 27218069; PubMed Central PMCID: PMCPMC4853157.
   PubMed Web of Science ®Google Scholar
• Lowe FC, Ku JC. Phytotherapy in treatment of benign prostatic hyperplasia: a critical review. Urology. 1996 Jul;48(1): 12–20. PubMed PMID: 8693632.
   PubMed Web of Science ®Google Scholar
• Curtis Nickel J, Shoskes D, Roehrborn CG, et al. Nutraceuticals in prostate disease: the urologist’s role. Rev Urol. 2008 Summer;10(3):192–206. Pub-Med PMID: 18836556; PubMed Central PMCID: PMCPMC2556486.
   PubMedGoogle Scholar
• Wilt TJ, Ishani A, Rutks I, et al. Phytotherapy for benign prostatic hyperplasia. Public Health Nutr. 2000 Dec;3(4A):459–472. PubMed PMID: 11276294.
   PubMedGoogle Scholar
• Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res. 2008 Dec;20(Suppl 3):S11–S18. PubMed PMID: 19002119.
   PubMed Web of Science ®Google Scholar
• Izumi K, Mizokami A, Lin WJ, et al. Androgen receptor roles in the development of benign prostate hyperplasia. Am J Pathol. 2013 Jun;182(6):1942–1949. PubMed PMID: 23570837; PubMed Central PMCID: PMCPMC3668026.
   PubMed Web of Science ®Google Scholar
• Raheem OA, Parsons JK. Associations of obesity, physical activity and diet with benign prostatic hyperplasia and lower urinary tract symptoms. Curr Opin Urol. 2014 Jan;241:10–14. PubMed PMID: 24247174.
   PubMed Web of Science ®Google Scholar
• Minciullo PL, Inferrera A, Navarra M, et al. Oxidative stress in benign prostatic hyperplasia: a systematic review. Urol Int. 2015;94(3):249–254.
   PubMed Web of Science ®Google Scholar
• de Morais Cardoso L, Pinheiro SS, Martino HSD, et al. Sorghum (Sorghum bicolor L.): Nutrients, bioactive compounds, and potential impact on human health. Crit Rev Food Sci Nutr. 2017;57(2):372–390.
   PubMed Web of Science ®Google Scholar
• Darvin P, Joung YH, Nipin S, et al. Sorghum polyphenol suppresses the growth as well as metastasis of colon cancer xenografts through co-targeting jak2/STAT3 and PI3K/Akt/mTOR pathways. J Funct Foods. 2015;15:193–206.
   Web of Science ®Google Scholar
• Park JH, Darvin P, Lim EJ, et al. Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts. PLoS One. 2012;7(7):e40531.
   PubMed Web of Science ®Google Scholar
• Ryu J-M, Jang GY, Woo KS, et al. Effects of sorghum ethyl-acetate extract on PC3M prostate cancer cell tumorigenicity. J Funct Foods. 2017;37:449–459.
   Web of Science ®Google Scholar
• Awika JM, Rooney LW. Sorghum phytochemicals and their potential impact on human health. Phytochemistry. 2004;65(9):1199–1221.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Untergasser G, Madersbacher S, Berger P. Benign prostatic hyperplasia: age-related tissue-remodeling. Exp Gerontol. 2005 Mar;403:121–128. PubMed PMID: 15763388.
   PubMed Web of Science ®Google Scholar
• Ammar AE, Esmat A, Hassona MD, et al. The effect of pomegranate fruit extract on testosterone‐induced BPH in rats. Prostate. 2015;75(7):679–692.
   PubMed Web of Science ®Google Scholar
• Masrudin S, Mohamad J. Preventive effect of Pueraria mirifica on testosterone‐induced prostatic hyperplasia in Sprague Dawley rats. Andrologia. 2015;47(10):1153–1159.
   PubMed Web of Science ®Google Scholar
• Atawia RT, Tadros MG, Khalifa AE, et al. Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in rats. Toxicol Lett. 2013 May;219(2):160–169. PubMed PMID: 23500659.
   PubMed Web of Science ®Google Scholar
• Park JH, Lee SH, Chung I-M, et al. Sorghum extract exerts an anti-diabetic effect by improving insulin sensitivity via PPAR-γ in mice fed a high-fat diet. Nutr Res Pract. 2012;6(4):322–327.
   PubMed Web of Science ®Google Scholar
• Shim T-J, Kim TM, Jang KC, et al. Toxicological evaluation and anti-inflammatory activity of a golden gelatinous sorghum bran extract. Biosci Biotechnol Biochem. 2013;77(4):697–705.
   PubMed Web of Science ®Google Scholar
• Elkahwaji JE. The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer. Res Rep Urol. 2013;5:1.
   Google Scholar
• Wang Z, Olumi AF. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia. Differentiation. 2011;82(4–5):261–271.
   PubMed Web of Science ®Google Scholar
• Huang Y, Chen H, Zhou X, et al. Inhibition effects of chlorogenic acid on benign prostatic hyperplasia in mice. Eur J Pharmacol. 2017;809:191–195.
   PubMed Web of Science ®Google Scholar
• Jung Y, Park J, Kim H-L, et al. Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells. Oncotarget. 2017;8(50):87194.
   PubMedGoogle Scholar
• Pagano E, Laudato M, Griffo M, et al. Phytotherapy of benign prostatic hyperplasia. A minireview. Minireview Phytother Res. 2014;28(7):949–955.
   PubMed Web of Science ®Google Scholar
• Takeda H, Nakamoto T, Kokontis J, et al. Autoregulation of androgen receptor expression in rodent prostate: immunohistochemical and in situ hybridization analysis. Biochem Biophys Res Commun. 1991;177(1):488–496.
   PubMed Web of Science ®Google Scholar
• Torres JM, Ruiz E, Ortega E. Development of a quantitative RT‐PCR method to study 5α‐reductase mRNA isozymes in rat prostate in different androgen status. Prostate. 2003;56(1):74–79.
   PubMed Web of Science ®Google Scholar
• Zhu YS, Imperato‐McGinley JL. 5α‐reductase isozymes and androgen actions in the prostate. Ann NY Acad Sci. 2009;1155(1):43–56.
   PubMed Web of Science ®Google Scholar
• Carson C, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology. 2003;61(4):2–7.
   PubMed Web of Science ®Google Scholar
• Mosli HH, Esmat A, Atawia RT, et al. Metformin attenuates testosterone-induced prostatic hyperplasia in rats: a pharmacological perspective. Sci Rep. 2015 Oct;5:15639. PubMed PMID: 26492952; PubMed Central PMCID: PMCPMC4616049.
   PubMed Web of Science ®Google Scholar
• Lee G, Shin J, Choi H, et al. Cynanchum wilfordii ameliorates testosterone-induced benign prostatic hyperplasia by regulating 5α-reductase and androgen receptor activities in a rat model. Nutrients. 2017;9(10):1070.
   Web of Science ®Google Scholar
• Shin SJ, Lee KH, Chung KS, et al. The traditional Korean herbal medicine Ga-Gam-Nai-Go-Hyan suppresses testosterone-induced benign prostatic hyperplasia by regulating inflammatory responses and apoptosis. Exp Ther Med. 2017;13(3):1025–1031.
   PubMed Web of Science ®Google Scholar
• Banerjee PP, Banerjee S, Brown TR. Bcl-2 protein expression correlates with cell survival and androgen independence in rat prostatic lobes. Endocrinology. 2002;143(5):1825–1832.
   PubMed Web of Science ®Google Scholar
• Vital P, Castro P, Ittmann M. Oxidative stress promotes benign prostatic hyperplasia. Prostate. 2016;76(1):58–67.
   PubMed Web of Science ®Google Scholar
• Tothova L, Celec P, Ostatnikova D, et al. Effect of exogenous testosterone on oxidative status of the testes in adult male rats. Andrologia. 2013 Dec;45(6):417–423. PubMed PMID: 23121168.
   PubMed Web of Science ®Google Scholar
• Biri H, Öztürk HS, Kaçmaz M, et al. Activities of DNA turnover and free radical metabolizing enzymes in cancerous human prostate tissue. Cancer Invest. 1999;17(5):314–319.
   PubMed Web of Science ®Google Scholar